estradiol sun 10 micrograms vaginal tablets
sun pharmaceutical industries europe b.v. - estradiol - vaginal tablet - 10 microgram(s) - estradiol
dermestril-septem 50 micrograms/24hours transdermal patch
rottapharm ltd - estradiol - transdermal patch - 50 microgram(s)/24 hours - natural and semisynthetic estrogens, plain; estradiol
dermestril-septem 25 micrograms/24hours transdermal patch
rottapharm ltd - estradiol - transdermal patch - 25 microgram(s)/24 hours - natural and semisynthetic estrogens, plain; estradiol
dermestril-septem 75 micrograms/24 hours transdermal patch
rottapharm ltd - estradiol - transdermal patch - 75 microgram(s)/24 hours - natural and semisynthetic estrogens, plain; estradiol
estrofem 2 mg film-coated tablets
novo nordisk a/s - estradiol anhydrous - film-coated tablet - 2 milligram(s) - natural and semisynthetic estrogens, plain; estradiol
estradot 25 micrograms/24 hours, transdermal patch
novartis ireland limited - estradiol hemihydrate - transdermal patch - 25 microgram(s)/24 hours - natural and semisynthetic estrogens, plain; estradiol
evorel 50 micrograms per 24 hours transdermal patch
janssen sciences ireland uc - estradiol hemihydrate - transdermal patch - 50 microgram(s)/24 hours - natural and semisynthetic estrogens, plain; estradiol
mesalin solution for injection, 0.2mg/ml
intervet ireland limited - estradiol benzoate - solution for injection - 0.2 mg/ml - canine - hormone
mesalin 0.2 mg/ml solution for injection
intervet uk ltd - oestradiol benzoate -
estrofem 2 mg
novo nordisk ltd., israel - estradiol as hemihydrate - film coated tablets - estradiol as hemihydrate 2 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.the experience treating women older than 65 years is limited.